Established theory of radiation-induced decay is not generalizable to Bolton-Hunter labeled peptides

Biochemical Pharmacology

Volumn 65, Issue 9, 2003, Pages 1515-1520

  Doran, Amanda C ^a   Wan, Yieh Ping ^b   Kopin, Alan S ^a   Beinborn, Martin ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b PERKINELMER INC   (United States)

Author keywords

Cholecystokinin; Glucagon like peptide; Peptide hormone; Radioactive decay; Radioligand; Receptor

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CYCLIC AMP; GLUCAGON LIKE PEPTIDE 2; INOSITOL PHOSPHATE; IODINE 125; RADIOLIGAND;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; ISOTOPE LABELING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RADIOIODINATION; RADIOISOTOPE DECAY; SIGNAL TRANSDUCTION;

EID: 0038403725     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00103-5     Document Type: Article

References (22)

1. 125I -labeled peptides Methods Mol. Biol. 73:1997;323-329.
2. 131I -labelled human growth hormone of high specific activity Nature. 194:1962;495-496.
3. 125I -containing acylating agent Biochem. J. 133:1973;529-539.
4. 125I -labeled peptides and their purification by reversed-phase high performance liquid chromatography Methods Mol. Biol. 73:1997;231-237.
5. McFarthing KG. Selection and synthesis of receptor-specific radioligands. In: Irvine GB, Williams CH, editors. Receptor-ligand interactions: a practical approach. New York: Oxford University Press; 1997. p. 1-18.
6. 125I decay in o-iodotyrosine Radiat. Res. 82:1980;467-477.
7. 125I -Tyr-54-α-bungarotoxin J. Biol. Chem. 259:1984;1160-1166.
8. Deutzmann R., Stocklin G. Chemical effects of iodine-125 decay in aqueous solution of 5-iodouracil: ring fragmentation as a consequence of the Auger effect. Radiat. Res. 87:1981;24-36.
9. Hofer K.G., Keough G., Smith J.M. Biological toxicity of Auger emitters: molecular fragmentation versus electron irradiation. Curr. Top. Radiat. Res. Q. 1:1978;335-354.
10. 125I ]monoiodoinsulin: preparation, biologic properties and long-term stability Diabetes. 30:1981;1-8.
11. Pearson R.K., Hadac E.M., Miller L.J. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated. Gastroenterology. 90:1986;1985-1991.
12. Lee Y.M., Beinborn M., McBride E.W., Lu M., Kolakowski L.F. Jr., Kopin A.S. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J. Biol. Chem. 268:1993;8164-8169.
13. Munroe D.G., Gupta A.K., Kooshesh F., Vyas T.B., Rizkalla G., Wang H., Demchyshyn L., Yang Z.J., Kamboj R.K., Chen H., McCallum K., Sumner-Smith M., Drucker D.J., Crivici A. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1569-1573.
14. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
15. Beinborn M., Quinn S.M., Kopin A.S. Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties. J. Biol. Chem. 273:1998;14146-14151.
16. Tibaduiza E.C., Chen C., Beinborn M. A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain. J. Biol. Chem. 276:2001;37787-37793.
17. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., Roques B.P. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51:1999;745-781.
18. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology. 122:2002;531-544.
19. 31-39: a non-oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides J. Immunoassay. 5:1984;99-120.
20. Bolander F.F. Jr., Fellows R.E. Growth hormone covalently bound to Sepharose or glass. Analysis of ligand release rates and characterization of soluble radiolabeled products. Biochemistry. 14:1975;2938-2943.
21. Hulme EC, Birdsall NJM. Strategy and tactics in receptor-binding studies. In: Hulme EC, editor. Receptor-ligand interactions: a practical approach. New York: Oxford University Press; 1992. p. 63-176.
22. Jeffries W.B., Waugh D., Abel P.W. Analysis of data from "cold saturation" radioligand binding experiments. Methods Mol. Biol. 73:1997;331-342.